A Type III CRISPR Ancillary Ribonuclease Degrades Its Cyclic Oligoadenylate Activator. (2019)
Attributed to:
Cyclic oligoadenylate signalling - a new type of antiviral response
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jmb.2019.04.041
PubMed Identifier: 31071326
Publication URI: http://europepmc.org/abstract/MED/31071326
Type: Journal Article/Review
Volume: 431
Parent Publication: Journal of molecular biology
Issue: 15
ISSN: 0022-2836